Premium
Retraction statement: ‘Long‐term efficacy and safety of blonanserin in patients with first‐episode schizophrenia: A 1‐year open‐label trial’ by Y. Ninomiya, S. Miyamoto, T. Tenjin, S. Ogino, N. Miyake, Y. Kaneda, T. Sumiyoshi and N. Yamaguchi
Publication year - 2017
Publication title -
psychiatry and clinical neurosciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.609
H-Index - 74
eISSN - 1440-1819
pISSN - 1323-1316
DOI - 10.1111/pcn.12533
Subject(s) - medicine , clinical trial , family medicine , psychiatry , psychology , library science , computer science